The way I understand these things is, as part of the Long Term Incentive Plan, Cyclopharm has issued the shares to an employee as a no cost loan. Yes, this does signal a high degree of confidence that approval will be granted and that the shares will move much higher on the news. What I can't work out is, how did they determine the price of $3.04?
Also, thinking we will hear the FDA decision news on the 29th and not before.
The way I understand these things is, as part of the Long Term...
Add CYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.60 |
Change
-0.050(3.03%) |
Mkt cap ! $150.7M | |||
| Open | High | Low | Value | Volume |
| $1.62 | $1.62 | $1.60 | $16.89K | 10.54K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2025 | $1.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.62 | 8518 | 2 |
View Market Depth
| Last trade - 16.10pm 17/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.60 |
Change
-0.050 ( 2.44 %) |
||||
| Open | High | Low | Volume | ||
| $1.62 | $1.62 | $1.60 | 1820 | ||
| Last updated 13.40pm 17/05/2024 ? | |||||
| CYC (ASX) Chart |